However, the rapid change of clinical stage (T1c to T2b), the increase in number to positive cores (1 of 6 to 4 of 6) and the accelerated PSA and PAP kinetics suggest there could be a B12 prostate cancer interaction. This evidence concerns the gene KLK3 and prostate carcinoma.